Recent News

• 03.17.2026 - Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting
• 03.03.2026 - Immunocore to present at upcoming investor conferences
• 02.25.2026 - Immunocore reports fourth quarter and full year 2025 financial results and provides a business update
• 02.18.2026 - Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2026
• 01.30.2026 - Immunocore announces R&D leadership evolution

Recent Filings

• 03.11.2026 - 144 Report of proposed sale of securities
• 03.06.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.25.2026 - EX-99.1 EX-99.1
• 02.25.2026 - 8-K Current report
• 02.25.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.19.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2026 - 4 Statement of changes in beneficial ownership of securities